Dodder Seeds MarketSize, Share & Industry Analysis, 2026-2034By TypeBy ApplicationBy FormBy Distribution ChannelBy End User

Dodder seed refers to the dried ripe seed of Cuscuta plant species, most commonly Cuscuta chinensis, used across traditional medicine, dietary supplement and personal-care formulations for its documented use in tonic and reproductive-health preparations. The seed is supplied in raw whole form as well as processed into powders, extracts and oils depending on the end application. Buyers range from traditional medicine practitioners and herbal formulators sourcing raw material directly, to nutraceutical, pharmaceutical and cosmetics manufacturers that require standardized extract-grade input for branded finished products.

The global dodder seeds market stood at USD 62.5 million in 2025. A forecast-period rate of 7.8% takes it to USD 121.79 million by 2034, and the study reports every year in between, passing USD 47 million in 2020, USD 59.6 million in 2024, USD 66.8 million in 2026 and USD 90.21 million in 2030.

On the type axis, growth rates run from 6.91% for Chinese Dodder Seed up to 9.9% for California Dodder Seed. Chinese Dodder Seed carries the volume: USD 39.06 million and 62.5% of revenue in 2025, USD 70.64 million and 58% in 2034. The lines gaining share are Australian Dodder Seed and California Dodder Seed. Chinese Dodder Seed lose share without losing revenue.

Cut by application, the largest line is Herbal Medicine: 47.98% of 2025 revenue, worth USD 29.99 million, and 42% at USD 51.15 million by 2034. Dietary Supplements grows faster at 9.3% against 6.12%, moving from 35.01% of revenue to 40% by 2034. Both this axis and the type one divide the same revenue, which is why they are alternative views rather than components.

USD 28.39 million of 2025 revenue is generated in Asia Pacific, 45.42% of the global total and the largest regional share; it reaches USD 58.46 million by 2034. North America is next at 22.29% and USD 13.93 million, and Middle East and Africa last at 6%. Because Asia Pacific take share, the revenue added by 2034 concentrates rather than spreading across all five regions.

The 2025 total is a triangulation of published figures and category proxies rather than a directly sourced total. Segment, regional and country splits are estimated on the same basis, which bounds the precision of the figures above. Coverage runs to five regions, three type lines and five segmentation axes across a fifteen-year window.

• The global dodder seeds market moves from USD 47 million in 2020 to USD 62.5 million in 2025 and USD 121.79 million by 2034, the forecast period compounding at 7.8% a year.
• Chinese Dodder Seed is the largest type line at USD 39.06 million in 2025, a 62.5% share, reaching USD 70.64 million and 58% of revenue by 2034.
• Fastest growth on the type axis belongs to California Dodder Seed: 9.9% a year, USD 10.49 million to USD 24.36 million, and a share moving from 16.78% to 20%.
• Against a base case of USD 121.79 million in 2034, the study also reports a bear case at USD 103.84 million and a bull case at USD 141.47 million, with the assumptions behind each set out separately.
• Asia Pacific holds 45.42% of global revenue in 2025 at USD 28.39 million, the largest of the five regions tracked, and reaches USD 58.46 million by 2034.
• China accounts for 55% of Asia Pacific in the base year, worth USD 15.61 million in 2025 and reaching USD 30.7 million by 2034, the worked country example carried through that region's chapters.
• The study covers 2020 through 2034 with 2025 as the base year, reporting five regions and five segmentation axes separately, with revenue, share and a growth rate for every line in each year.

The global dodder seeds market is shaped over 2026-2034 by three measurable movements: a change in the type mix, a shift in where revenue sits geographically, and the 7.8% rate carrying the total.

Not one of them points downward. Growth is everywhere in absolute terms, and the interest is entirely in where it lands.

The type mix tilts toward California Dodder Seed. 9.9% against 6.91%: that gap, between California Dodder Seed and Chinese Dodder Seed, is the largest on the type axis. California Dodder Seed takes its share of revenue from 16.78% to 20% while Chinese Dodder Seed gives up ground, from 62.5% to 58%. Revenue rises on both sides; USD 10.49 million to USD 24.36 million and USD 39.06 million to USD 70.64 million respectively, so this is a change in composition, not a contraction, and one forecast window is long enough for it to matter.

Asia Pacific gain regional share. Asia Pacific moves from 45.42% of revenue in 2025 to 48% in 2034, worth USD 28.39 million rising to USD 58.46 million. The remaining regions grow in absolute terms while giving up share: North America at 22.29% moving to 21%, Europe at 18.29% moving to 17%, Latin America at 8% moving to 8%, Middle East and Africa at 6% moving to 6%. That makes the regional split worth reading rather than scaling from the global rate: the same market rate produces different outcomes depending on where a supplier's revenue sits.

Growth compounds at 7.8% without a step change. Fifteen years of revenue run USD 47 million in 2020, USD 59.6 million in 2024, USD 62.5 million in 2025, USD 66.8 million in 2026, USD 90.21 million in 2030 and USD 121.79 million in 2034. The forecast rate of 7.8% sits against 5.86% over the historical period, so the projection extends an observed trend instead of proposing a new one. For a participant that makes planning a question of capturing a share of steady expansion rather than timing a discontinuity, and it is why the type and regional mixes matter more to a forecast than the headline rate does.

Growth is concentrated in California Dodder Seed

The 7.8% forecast rate rests on three things that can be measured separately: the size of the existing base, the mix shift on the type axis, and where regional growth is concentrated.

The bear case and what drives it

Upside case: USD 141.47 million by 2034

The total depends on a single line

Asia Pacific holds 45.42% of the global dodder seeds market in 2025, worth USD 28.39 million with USD 58.46 million projected for 2034. That makes it the first-largest region covered, in 2025 and again in 2034.

Share climbs to 48% by 2034, so the region grows faster than the market's 7.8% and takes a larger part of the revenue added by 2034 than its 2025 weight implies.

The type mix reported at global level applies here, with Chinese Dodder Seed the largest line at 62.5% of 2025 revenue and California Dodder Seed the fastest-growing at 9.9%. Asia Pacific is reported axis by axis and country by country in the full study.

China is the largest market within Asia Pacific, generating USD 15.61 million in 2025 and projected to reach USD 30.7 million by 2034. It accounts for 55% of regional revenue in the base year, the largest single share without dominating the region outright. Against regional totals of USD 28.39 million in 2025 and USD 58.46 million in 2034, it is the country the full report breaks out in detail.

Composition here matches the global split: the largest line is Chinese Dodder Seed at 62.5% of 2025 revenue, easing to 58% by 2034, and the fastest is California Dodder Seed at 9.9%, from 16.78% to 20%. With 55% of Asia Pacific concentrated here, a change in this country's mix is visible in the regional figures instead of being diluted by its neighbours. The full report reports China by type separately.

In China, dodder seed is recognized as a traditional Chinese medicine material and falls under the oversight of the National Medical Products Administration, with quality attributes referenced against the Chinese Pharmacopoeia monograph for the crude drug. Suppliers sourcing or processing the seed for medicinal use must meet identity, purity, and processing requirements set out in that monograph, and manufacturers preparing it into patent medicines or extracts operate under Good Manufacturing Practice licensing. Where the seed enters trade as an agricultural commodity rather than a medicinal material, general phytosanitary and seed-quality inspection administered by agricultural authorities can also apply, alongside labelling that correctly identifies the botanical source and intended use.

In China the field is Nutra Green Biotechnology, Novoherb Technologies, Jiaherb, Xi'an Sost Biotech Co., Ltd., Shaanxi Undersun Biomedtech Co., Ltd., Xi'an Healthful Biotechnology Co., Ltd., Baoji Herb-Sea Biotechnology Co., Ltd. and Xi'an Sgonek Biological Technology Co., Ltd.. The commercially relevant division is 62.5% of 2025 revenue in Chinese Dodder Seed, where the volume is, against 9.9% growth in California Dodder Seed, where share moves. Country-level shares and positioning per company sit in the full report.

11.36% of global revenue is generated in India; USD 7.1 million in 2025, reaching USD 17.44 million in 2034, and 25.01% of Asia Pacific.

Within Asia Pacific, South Korea accounts for 12.01% of regional revenue and 5.46% of the global total, worth USD 3.41 million in 2025 and USD 6.27 million by 2034.

22.29% of the global dodder seeds market sits in North America in 2025, worth USD 13.93 million rising to USD 25.58 million in 2034. That makes it the second-largest region covered, in 2025 and again in 2034.

21% of global revenue sits here in 2034, below the 2025 level, and the region keeps growing in absolute terms while others expand faster, a change in relative weight, not a decline in demand.

Segment composition follows the global pattern: Chinese Dodder Seed largest at 62.5% of 2025 revenue, California Dodder Seed fastest at 9.9%. The full report breaks North America out along every axis and by country.

75.02% of North America's base-year revenue comes from the United States; USD 10.45 million, rising to USD 18.89 million by 2034. Carrying 75.02% of the region in the base year, it sets North America's direction rather than contributing to it. Set against USD 13.93 million and USD 25.58 million for the region, it is why this market rather than a smaller one is the one reported in full.

Demand in the United States follows the type mix reported at global level: Chinese Dodder Seed is the largest line at 62.5% of 2025 revenue, moving to 58% by 2034, while California Dodder Seed grows fastest at 9.9% and takes its share from 16.78% to 20%. Its 75.02% weight in North America means those movements carry straight into the regional totals. Per-type revenue for the United States appears on its own in the full report.

In the United States, dodder seed marketed as an herbal or dietary ingredient falls under the Food and Drug Administration's dietary supplement framework established by the Dietary Supplement Health and Education Act, which requires manufacturers to follow current Good Manufacturing Practice rules and to label products with accurate ingredient identity rather than unapproved disease claims. Because Cuscuta species are also classified as parasitic weeds, the seed is separately subject to noxious-weed and seed-purity oversight administered by the United States Department of Agriculture's Animal and Plant Health Inspection Service, which restricts movement of contaminated seed lots and can require certification that agricultural seed shipments are free of dodder before interstate sale.

Nutra Green Biotechnology, Novoherb Technologies, Jiaherb, Xi'an Sost Biotech Co., Ltd., Shaanxi Undersun Biomedtech Co., Ltd., Xi'an Healthful Biotechnology Co., Ltd., Baoji Herb-Sea Biotechnology Co., Ltd. and Xi'an Sgonek Biological Technology Co., Ltd. are the suppliers covered in the United States. Chinese Dodder Seed, at 62.5% of 2025 revenue, is where the volume sits, and California Dodder Seed, growing at 9.9%, is where position changes hands over the forecast period.

Canada is sized at USD 2.09 million in 2025, rising to USD 3.91 million by 2034; 3.34% of global revenue and 15% of North America. It is reported separately from the United States across every segmentation axis in the full report.

18.29% of the global dodder seeds market sits in Europe in 2025, worth USD 11.43 million with USD 20.7 million projected for 2034. By revenue it sits third across the study, and the ranking does not change between 2025 and 2034.

Its share moves to 17% by 2034, and the region keeps growing in absolute terms while others expand faster, a change in relative weight, not a decline in demand.

The type mix reported at global level applies here, with Chinese Dodder Seed the largest line at 62.5% of 2025 revenue and California Dodder Seed the fastest-growing at 9.9%. Revenue for Europe is broken out by every segmentation axis and by country in the full report.

The largest single market in Europe is Germany, at USD 4.57 million in 2025 and USD 8.05 million in 2034. Its 39.98% of base-year regional revenue leads the region, though enough sits elsewhere that Europe is not a proxy for it. The region itself runs USD 11.43 million to USD 20.7 million over the same period, and this is the market carrying the country-level detail in the full report.

Demand in Germany follows the type mix reported at global level: Chinese Dodder Seed is the largest line at 62.5% of 2025 revenue, moving to 58% by 2034, while California Dodder Seed grows fastest at 9.9% and takes its share from 16.78% to 20%. Since 39.98% of Europe's revenue is generated here, the regional numbers inherit this market's mix rather than smoothing it out. Germany carries its own type breakdown in the full report.

In Germany, dodder seed used within food supplements is governed by the European Union's food supplements framework together with national food law enforced by the Federal Office of Consumer Protection and Food Safety, requiring accurate ingredient labelling and safety substantiation rather than medicinal claims unless separately authorized. Where the material is presented as a traditional herbal medicinal product, the Federal Institute for Drugs and Medical Devices applies the EU's traditional-use registration route, which calls for evidence of long-standing traditional application and compliant quality and labelling documentation. As an agricultural seed contaminant, Cuscuta is additionally addressed under German and EU seed-purity rules restricting its presence in certified crop seed lots.

Nutra Green Biotechnology, Novoherb Technologies, Jiaherb, Xi'an Sost Biotech Co., Ltd., Shaanxi Undersun Biomedtech Co., Ltd., Xi'an Healthful Biotechnology Co., Ltd., Baoji Herb-Sea Biotechnology Co., Ltd. and Xi'an Sgonek Biological Technology Co., Ltd. are the suppliers covered in Germany. The commercially relevant division is 62.5% of 2025 revenue in Chinese Dodder Seed, where the volume is, against 9.9% growth in California Dodder Seed, where share moves.

France is sized at USD 2.51 million in 2025, rising to USD 4.61 million by 2034; 4.02% of global revenue and 21.96% of Europe. It is reported separately from Germany across every segmentation axis in the full report.

USD 5 million of 2025 revenue is generated in Latin America, 8% of the global dodder seeds market with USD 9.74 million projected for 2034. That makes it the fourth-largest region covered, in 2025 and again in 2034.

8% of global revenue sits here in 2034, below the 2025 level, while nothing contracts here; other regions simply grow faster, which shows up as relative weight rather than as falling revenue.

Chinese Dodder Seed leads here as it does globally, at 62.5% of 2025 revenue, and California Dodder Seed again grows fastest at 9.9%. Per-axis and per-country detail for Latin America sits in the full report.

Brazil is the largest market within Latin America, generating USD 2.75 million in 2025 and projected to reach USD 5.27 million by 2034. 55% of the region in the base year makes it the largest market here without making it the region. The region itself runs USD 5 million to USD 9.74 million over the same period, and this is the market carrying the country-level detail in the full report.

Brazil buys along the same lines as the market globally; Chinese Dodder Seed first at 62.5% of 2025 revenue and 58% in 2034, California Dodder Seed fastest at 9.9% on a share moving from 16.78% to 20%. Its 55% weight in Latin America means those movements carry straight into the regional totals. The full report reports Brazil by type separately.

In Brazil, dodder seed intended for phytotherapeutic or herbal supplement use falls under the National Health Surveillance Agency, which requires registration or notification of herbal products with supporting quality, safety, and labelling documentation consistent with its rules for traditional plant-based medicines. Separately, because Cuscuta is classified as a parasitic weed of agricultural concern, the Ministry of Agriculture and Livestock oversees seed-purity and phytosanitary standards for crop seed, restricting the presence of dodder in certified seed lots and requiring inspection of shipments that could carry the weed. Suppliers moving the seed across these two uses must satisfy whichever regime applies to the product's declared purpose.

The suppliers tracked in this study (Nutra Green Biotechnology, Novoherb Technologies, Jiaherb, Xi'an Sost Biotech Co., Ltd., Shaanxi Undersun Biomedtech Co., Ltd., Xi'an Healthful Biotechnology Co., Ltd., Baoji Herb-Sea Biotechnology Co., Ltd. and Xi'an Sgonek Biological Technology Co., Ltd.) compete in Brazil across the type lines above. Chinese Dodder Seed, at 62.5% of 2025 revenue, is where the volume sits, and California Dodder Seed, growing at 9.9%, is where position changes hands over the forecast period.

Within Latin America, Mexico accounts for 25% of regional revenue and 2% of the global total, worth USD 1.25 million in 2025 and USD 2.5 million by 2034.

In Middle East and Africa, 6% of global revenue puts 2025 at USD 3.75 million and reaches USD 7.31 million by 2034. That makes it the fifth-largest region covered, in 2025 and again in 2034.

Its share moves to 6% by 2034, a shift in share rather than in direction: revenue climbs every year while the market's centre of gravity moves elsewhere.

The type mix reported at global level applies here, with Chinese Dodder Seed the largest line at 62.5% of 2025 revenue and California Dodder Seed the fastest-growing at 9.9%. Revenue for Middle East and Africa is broken out by every segmentation axis and by country in the full report.

USD 1.5 million of Middle East and Africa's 2025 revenue is generated in South Africa, the region's largest market, reaching USD 2.83 million by 2034. At 40% of the region in 2025 it leads, but a majority of Middle East and Africa's revenue is generated in other markets. Regional revenue of USD 3.75 million in 2025 and USD 7.31 million in 2034 sits around it, and it is the country used wherever the full report cuts a figure by geography.

Composition here matches the global split: the largest line is Chinese Dodder Seed at 62.5% of 2025 revenue, easing to 58% by 2034, and the fastest is California Dodder Seed at 9.9%, from 16.78% to 20%. Its 40% weight in Middle East and Africa means those movements carry straight into the regional totals. South Africa carries its own type breakdown in the full report.

In South Africa, dodder is listed as a declared weed under agricultural legislation administered by the national Department of Agriculture, so seed lots intended for planting or crop trade must meet purity standards under the Plant Improvement Act framework that restrict its presence and can require inspection or certification before sale. Where dodder seed is instead marketed as a complementary or herbal medicine ingredient, the South African Health Products Regulatory Authority applies its framework for complementary medicines, requiring appropriate product notification, quality evidence, and truthful labelling of the botanical source and intended use. Suppliers must therefore align with whichever regime matches the seed's declared commercial purpose.

In South Africa the field is Nutra Green Biotechnology, Novoherb Technologies, Jiaherb, Xi'an Sost Biotech Co., Ltd., Shaanxi Undersun Biomedtech Co., Ltd., Xi'an Healthful Biotechnology Co., Ltd., Baoji Herb-Sea Biotechnology Co., Ltd. and Xi'an Sgonek Biological Technology Co., Ltd.. Volume sits in Chinese Dodder Seed at 62.5% of 2025 revenue; movement sits in California Dodder Seed at 9.9% growth.

1.68% of global revenue is generated in the United Arab Emirates; USD 1.05 million in 2025, reaching USD 2.19 million in 2034, and 28% of Middle East and Africa.

Request this sample to see the full data tables and segment-level detail behind this analysis.

This report assesses the market across every segment, with revenue and a growth rate for each line in each year of the study period. It covers the drivers, trends, opportunities, restraints and challenges shaping growth, the competitive landscape and the companies profiled, and the research methodology behind every estimate. Segmentation is reported by Type, Application, Form, Distribution Channel, End User, and regional analysis covers Asia Pacific, North America, Europe, Latin America, Middle East and Africa, each broken out by country.